ArticleJournal of medicinal chemistry2019

Development of Novel Epoxyketone-Based Proteasome Inhibitors as a Strategy To Overcome Cancer Resistance to Carfilzomib and Bortezomib.

Min Jae Lee et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.